Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis onset during etanercept treatment.

× No keyword cloud information.

14 in total

Review 1. New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.

Authors: Takumi Matsumoto; Ichiro Nakamura; Ayumi Miura; Gen Momoyama; Katsumi Ito
Journal: Clin Rheumatol Date: 2012-11-14 Impact factor: 2.980

Review 2. Adverse reactions to biologic agents and their medical management.

Authors: Onur Boyman; Denis Comte; François Spertini
Journal: Nat Rev Rheumatol Date: 2014-08-12 Impact factor: 20.543

Review 3. Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors: Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal: Drug Saf Date: 2017-09 Impact factor: 5.606

4. Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1.

Authors: Melissa A Landek-Salgado; Noel R Rose; Patrizio Caturegli
Journal: J Autoimmun Date: 2011-07-23 Impact factor: 7.094

Review 5. Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors: S Weidauer; M Nichtweiss; E Hattingen
Journal: Clin Neuroradiol Date: 2014-02-12 Impact factor: 3.649

Review 6. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Authors: Edward Tobinick
Journal: CNS Drugs Date: 2009-09 Impact factor: 5.749

Review 7. Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors: Brian A Baldo
Journal: Drug Saf Date: 2015-05 Impact factor: 5.228

Review 8. Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system.

Authors: Elsa How Shing Koy; Pierre Labauge; Athan Baillet; Clément Prati; Hubert Marotte; Yves-Marie Pers
Journal: Ther Adv Musculoskelet Dis Date: 2021-07-09 Impact factor: 5.346

9. Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.

Authors: E Andreadou; E Kemanetzoglou; Ch Brokalaki; M E Evangelopoulos; C Kilidireas; A Rombos; E Stamboulis
Journal: Case Rep Neurol Med Date: 2013-05-16

10. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Authors: Evripidis Kaltsonoudis; Anastasia K Zikou; Paraskevi V Voulgari; Spyridon Konitsiotis; Maria I Argyropoulou; Alexandros A Drosos
Journal: Arthritis Res Ther Date: 2014-06-17 Impact factor: 5.156